Trainee (HMA-EMA Catalogue of real-world data studies: Are transparency recommendations followed?)

Type of position:  Trainee
Job Type:  06 May 2026 23:59 CET

Selection procedure reference: EMA/TR/11375 

Deadline for applications: 06 May 2026 23:59 CET 

 

The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.

 

This traineeship opportunity is now open for applications until 06 May 2026 23:59 CET, with an intake on 1 October 2026.

About the traineeship programme

The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master's students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.

Placement description

We are looking for a trainee in the Real World Evidence Office.

Specific objectives and projects

The Heads of Medicines Agencies-European Medicines Agency (HMA-EMA) Catalogue of real-world data (RWD) studies, launched in 2024, is a centralised publicly available repository of RWD studies from across the globe, with records maintained by study investigators. The RWD study Catalogue aims to enhance transparency and reproducibility in RWD research and support the use of RWD in the context of investigating the use, safety and effectiveness of medicines. It enables registration of non-interventional (RWD / observational) studies using a structured metadata model supporting consistent cataloguing across the study lifecycle. Metadata represent key study characteristics, including study design, population, outcomes, timelines and data sources used. The RWD study Catalogue supports the registration of study protocols prior to study initiation, with the possibility to upload multiple versions to document amendments over time. The upload of study results and other study resources is also highly encouraged. It is openly accessible and supports free-text search, filtering, and export functions.
As of December 2025, the RWD study Catalogue hosts 3,238 studies distributed across various regions, with 62% conducted exclusively in European countries. On average, 25 new studies are added per month. Voluntary registrations account for 56% of the studies, while the remainder are regulatory-mandated. Studies span all lifecycle stages, with currently 462 classified as planned, 931 ongoing, 1,833 completed and 12 discontinued or cancelled. Of these studies, 59% include a study protocol, and 50% provide additional study materials such as results or links to external repositories containing analytical code.
These descriptive statistics showcase the contribution of the RWD study Catalogue in improving transparency in RWD research, but they also highlight some of the limitations that we would like to further explore.
With this in mind, the trainee will:
• be involved in identifying the studies according to a clear cut-off date and lifecycle stage (based on clear inclusion and exclusion criteria),
• contribute to a review of recorded documents (protocol as from ongoing stage, report as from finalised stage), according to source of funding (public / private), disease area, study type,
• describe the timing of availability, assessing whether there is a trend towards improvement (quicker availability after study start and / or finalisation) and the type of information missing,
• contribute to recommendations on how this could be improved based on the analysis performed to inform the process (including through discussions with some of our stakeholders, such as industry via the focus group on RWD/RWE), with the ultimate aim of identifying whether adaptations to the process may be needed and communicating these findings clearly to our stakeholders.
This activity will be important as, by improving discoverability and traceability of RWD studies, the RWD study Catalogue supports study planning, knowledge sharing, reproducibility, and promotes good research practices.

Learning outcomes

• Understand how complete is the RWD study Catalogue when it comes to recommendations on proper study documentation (protocol and report upload)
• Identify and assess factors that may infuence this transparency effort
• Assess what are the current limitations (process-related or not) and discuss with some of our stakeholders to try to understand how this could be improved so that the impact of the registered studies is optimised to support the EMA (and other stakeholders) activities
• Gain knowledge of the Agency’s processes and procedures in the support to the generation of real-world evidence for regulatory decision making

 

Eligibility criteria

To be eligible for consideration for this placement, you are required to:

  1. enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
  2. possess a university degree in pharmacoepidemiology, biostatistics, medicine, pharmacy or biology (minimum of three years or more) that must have been obtained between 6 May 2025 and 6 May 2026 or be a university student on an Erasmus + or a similar programme or a PhD student or a Master's student with a previous fully finished degree in the areas mentioned before.
  3. a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages

 

For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.

Additional skills

Demonstrated experience in data analysis, clinical research, or regulatory processes, combined with a strong interest in real-world data/evidence with skills in analytics.

Behavioural Competencies

You will demonstrate the following behavioural competencies:

  • Communication skills
  • Interpersonal skills
  • Working with others
  • Adaptability
  • Research and analytical skills
  • Learning and development

Conditions of traineeship

The traineeship is offered for 10 months (1 October 2026 – 31 July 2027) and takes place at the Agency’s premises in Amsterdam with possibility for teleworking up to 40% of working time from The Netherlands and occasional teleworking from outside The Netherlands. Traineeships are offered for either full-time or part-time (80% or 50%) if combined with university studies.

The Agency pays a monthly stipend of €2,049.77 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining the Agency.

Each trainee will have a mentor at the Agency who will guide the trainee through the programme.

The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available here.

Expected selection timelines

Deadline for applications  06 May 2026 23:59 CET 
Assessments (remote) From mid-June 2026 to mid-July 2026
Decision and offers  By end of July 2026
Placement start  1 October 2026

 

______________________________________________________________________________________________________

Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands

Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu

 

© European Medicines Agency, 2024. Reproduction is authorised provided the source is acknowledged.

Join us to work for every patient in Europe!

Who we are?

Serving a population of 500 million citizens, we promote and protect public animal health in EU Member States, as well as the countries of the European Economic Area, by ensuring that all medicines available on the EU market are safe, effective and of high quality. 

What do we offer?

  • Meaningful work contributing to protecting the health of every individual and animal in Europe within multinational, multidisciplinary team
  • Development opportunities (e.g. internal mobility, mentoring, peer coaching, career reflection programme, etc.)
  • Work-life balance (flexible working arrangements, teleworking, generous annual leave plus official holidays)

Benefits

(applicable only to Temporary and Contract vacancies) 

  • Initial 5 year contract with competitive monthly tax-free salary and household & children’s allowances (where applicable)
  • Privileges for expatriate staff including expatriation and education allowances (where appropriate) and additional home leave
  • Relocation assistance
  • Excellent  health insurance scheme and social benefits
  • Retirement Pension Plan 

Read more about Contracts and Salary

Useful links:

 


Job Segment: Database, Clinical Research, Law, Medical Research, Pharmacy, Technology, Healthcare, Legal